WHO IGWG (Spanish)
Written by Judit Rius Sanjuan
Wednesday, 23 May 2007
Informe de KEI
Views on the IGWG
Written by James Love Continue Reading
Comments on the IGWG II bis
Thiru Balasubramaniam, Geneva Representative, Knowledge Ecology International
Sara Crager, MD/PhD Candidate '12 at Yale University/Universities Allied for Essential Medicines
Nicoletta Dentico, Policy and Advocacy Advisor, DNDi
Congressional Hearings in 110th U.S. Congress, on pharmaceutical drugs (including trade issues)
U.S. Senate
Appropriations Committee
Subcommittee on Labor, Health and Human Services, and Education
April 18, 2007 Hearing on Global Health
Judiciary Committee
June 6, 2007 Patent Reform: The Future of American Innovation
Committee on Health, Education, Labor, and Pensions
Survey of Patent Pools Demonstrates Variety of Purposes and Management Structures
Tuesday, 05 June 2007
An pdf version of this document is available here.
David Serafino[1]
Knowledge Ecology International
4 June 2007
Table of Contents
EMILA Working Plan
Saturday, 02 June 2007
The Essential Medical Inventions Licensing Agency
Working Plan, June 1, 2007
Introduction
Notes on the Bayh-Dole Act of 1980
Sep 2, 2009 The Bayh-Dole Act (or University and Small Business Patent Procedures Act) was originally enacted in 1980 as Public Law 96-517, and was amended in 1984 by Public Law 98-620. Among other things, the Bayh-Dole Act was designed… Continue Reading
Sept 10: Scope of Patentable Subject Matter, Bilski ruling
KEI is hosting a brownbag lunch to discuss the scope of patentable subject matter with reference to the Supreme Court's forthcoming decision on Bilski's appeal.
Bristol-Myers Squibb (BMS): Some Examples of Joint Ventures, Partnerships and Alliances
Tuesday, 28 August 2007
Joint Ventures, Partnerships and Alliances with Big Pharma (recent alliance updates can be found here):
Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership – This partnership sells and markets Plavix®. In 2006, the Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership sold in excess of $3.5 billion of Plavix® in the United States. Continue Reading
Novartis (NVS): Some Examples of Joint Ventures, Partnerships, and Alliances
Wednesday, 29 August 2007
According to the Novartis strategic alliances webpage, the company is engaged in "More than 400 collaborations in over 20 countries, over 120 collaborations with major biotech companies, and over 280 collaborations with academic centers."
Selected Joint Ventures, Partnerships, and Alliances with Big Pharma
Novartis and Bayer Schering AG – PTK/ZK – These two companies initially collaborated in the devel Continue Reading